|
|
|
By Tim Sandle, Ph.D. | The FDA recently released a draft guidance, Potency Assurance for Cellular and Gene Therapy Products. This article summarizes the draft guidance. The public comment period ends March 27, 2024. |
|
|
|
By Shalini Nagar, Research Nester | Here's a high-level summary of what is increasingly becoming an essential part of the downstream bioprocessing production line. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|